SwitchGear Genomics | SelectScience
SwitchGear Genomics products, product reviews and application articles on SelectScience.
Source: selectscience.net
Nathan Trinklein News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nathan Trinklein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nathan Trinklein Today - Breaking & Trending Today
Cancer biotech Rondo gets $67M to step on the gas with next-gen bispecific drugs
Rondo Therapeutics is developing bispecific antibody drugs capable of treating solid tumors, which have eluded this type of cancer therapy. Led by co-founders and Teneobio veterans Shelley Force Aldred and Nathan Trinklein, the biotech startup has emerged from stealth backed by a $67 million Series A round of funding.
Source: medcitynews.com
Rondo raises funding to advance solid tumour immuno-oncology platform
Rondo Therapeutics has raised $67m in a Series A financing round to advance next-generation immuno-oncology platform to treat solid tumours.
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
/PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors, today announced...
Source: prnewswire.com
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
/PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors, today announced...
Source: prnewswire.com